Zobrazeno 1 - 10
of 41
pro vyhledávání: '"C C, Nass"'
Publikováno v:
Transfusion. 39:1128-1135
BACKGROUND: Efforts to provide a safe, adequate blood supply have been inhibited by persistent shortages attributed to a lack of motivation on the part of the general public and inefficiency in recruiting processes. This study examined whether freque
Autor:
B, Wang, M J, Higgins, S, Kleinman, G B, Schreiber, E L, Murphy, S A, Glynn, D J, Wright, C C, Nass, D, Chang, M P, Busch
Publikováno v:
Transfusion. 44(8)
Increasing concern about transfusion transmission of variant Creutzfeldt-Jakob disease has resulted in indefinite deferral of transfused donors in France and the UK. Little is known, however, about the impact of indefinite deferral of transfused dono
Autor:
S E, Rugege-Hakiza, S A, Glynn, S T, Hutching, J, Bethel, C C, Nass, R L, McEntire, N V, Hirschler, J G, Campbell, A, Ladavac, G B, Schreiber
Publikováno v:
Transfusion. 43(8)
Blood donors with high-risk behaviors may not self-defer because they failed to read or understand the screening educational materials.In 1993, a total of 34,726 allogeneic donors responded to an anonymous mail survey of 50,162 donors that inquired a
Autor:
E L, Murphy, S M, Bryzman, S A, Glynn, D I, Ameti, R A, Thomson, A E, Williams, C C, Nass, H E, Ownby, G B, Schreiber, F, Kong, K R, Neal, G J, Nemo
Publikováno v:
Hepatology (Baltimore, Md.). 31(3)
Injection drug use (IDU) is a known risk factor for hepatitis C virus (HCV) infection, but the strength of other parenteral and sexual risk factors is unclear. In 1997, we performed a case-control study of 2,316 HCV-seropositive blood donors and 2,31
Publikováno v:
Transfusion. 39(10)
Efforts to provide a safe, adequate blood supply have been inhibited by persistent shortages attributed to a lack of motivation on the part of the general public and inefficiency in recruiting processes. This study examined whether frequency of donat
Autor:
E L, Murphy, S A, Glynn, J, Fridey, J W, Smith, R A, Sacher, C C, Nass, H E, Ownby, D J, Wright, G J, Nemo
Publikováno v:
Archives of internal medicine. 159(13)
To determine whether human T-lymphotropic virus type II (HTLV-II) infection is associated with an increased incidence of bacterial infections, we prospectively observed cohorts of HTLV-I- and HTLV-II-infected and seronegative subjects in 5 US cities.
Autor:
E L, Murphy, S A, Glynn, J, Fridey, R A, Sacher, J W, Smith, D J, Wright, B, Newman, J W, Gibble, D I, Ameti, C C, Nass, G B, Schreiber, G J, Nemo
Publikováno v:
The Journal of infectious diseases. 176(6)
Disease associations of human T lymphotropic virus types I and II (HTLV-I and -II) infection were studied in 154 HTLV-I-infected, 387 HTLV-II-infected, and 799 uninfected blood donors. Adjusted odds ratios (ORs) and 99% confidence intervals (CIs) wer
Autor:
T J Ryan, P Riedesel, B Maynard, Robert J. Bowman, Mary E. Clay, A W Shafer, M A Popovsky, C C Nass, D J Therkelsen
Publikováno v:
Transfusion. 37(9)
Background The movement of blood among different areas of the United States and the collection of more blood than is needed locally in some areas are increasing. Little is known of donors' attitudes about this blood resource sharing. Study design and
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 14(3)
In the United States, blood donors have been routinely screened for human T-cell lymphotropic virus (HTLV) since 1988. HTLV-I and -II seropositive blood donors have been identified through confirmatory testing at five participating blood centers and
Publikováno v:
Archives of pathologylaboratory medicine. 118(4)
In 1985, serologic testing became available to screen blood donors for the viruses associated with the acquired immunodeficiency syndrome; these viruses are now called human immunodeficiency viruses I and II. In 1989, blood donor screening for other